Quantitative Profiling

Phaseguides: A paradigm shift in microfluidic priming and emptying

Authors: 
P. Vulto, S. Podszun, P. Meyer, C. Hermann, A. Manz, G. Urban

DOI: 10.1039/C0LC00643B

Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator

Authors: 
van Beekum O, Fleskens V, Kalkhoven E.

doi:10.1038/oby.2008.473

Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin

Authors: 
Peter V. E. van den Berghe, Janneke M. Stapelbroek, Elmar Krieger, Prim de Bie, Stan F. J. van de Graaf, Reinoud E. A. de Groot, Ellen van Beurden, Ellen Spijker, Roderick H. J. Houwen, Ruud Berger, and Leo W. J. Klomp

DOI: 10.1002/hep.23209

Improving the analysis of designed studies by combining statistical modelling with study design information

Authors: 
U. Thissen, S.Wopereis, S.A.A. van den Berg, I.Bobeldijk, R. Kleemann, T. Kooistra, K.Willems van Dijk, B. van Ommen and A.K. Smilde

doi:10.1186/1471-2105-10-52

Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence.

Authors: 
de Keizer PL, Packer LM, Szypowska AA, Riedl-Polderman PE, van den Broek NJ, de Bruin A, Dansen TB, Marais R, Brenkman AB*, Burgering BM

Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research

Authors: 
Scalbert A, Brennan L, Fiehn O, Hankemeier T, Kristal BS, van Ommen B, Pujos-Guillot E, Verheij E, Wishart D, Wopereis S

DOI 10.1007/s11306-009-0168-0

Medullary thyroid carcinoma and biomarkers: past, present and future

Authors: 
W. van Veelen, J. W. B. de Groot, D. S. Acton, R. M. W. Hofstra, J. W. M. Hoppener, T. P. Links & C. J. M. Lips

 

DOI: 10.1111/j.1365-2796.2009.02106.x

Online capillary liquid-liquid electroextraction of peptides as fast pre-concentration prior to LC-MS

Authors: 
Lindenburg PW, Seitzinger R, Tempels FW, Tjaden UR, van der Greef J, Hankemeier T

DOI: 10.1002/elps.201000347

P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development

Authors: 
Wendy van Veelen , Rob Klompmaker , Martijn Gloerich, Carola J.R. van Gasteren, Eric Kalkhoven, Ruud Berger, Cornelis J.M. Lips, Rene H. Medema, Jo W.M. Hoppener and Dennis S. Acton

DOI: 10.1002/ijc.23977

Syndicate content